BioSpace News Archive

The Lung Health Foundation and Lung Cancer Canada have joined forces to highlight the hurtful and deadly effects of lung cancer stigma through Stop Asking the Wrong Question, a powerful new awareness campaign launched Canada-wide

Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced a partnership with Direct Scripts , a pharmacy solutions administrator focused on benefits management for self-insured employers. “We have forged a strategic partnership with Direct Scripts which will enable us to expand our Medication Therapy Management and MedWise™ medication safety review services to

Avenu’s Percutaneous Fistula Creation Technology Will Strengthen the Medtronic Peripheral Vascular Access Portfolio and Reinforce Medtronic’s Commitment to Improving Outcomes for Patients with End-Stage Renal Disease DUBLIN , Sept. 30, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Aven

Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, and US Oncology Research, one of the largest community-based oncology site management organizations in the U.S., announced today a collaboration to utilize the US Oncology Research Selected Trials for Accelerated Rollout (STAR) program for patient enrollment in the registration-enabling Phase 2 CRESTONE study

Shatterproof’s National Movement to End Stigma and online Addiction Treatment Needs Assessment Tool offer resources dedicated to better addressing the needs of those struggling with addiction

A Canadian Medical Device Licence was issued September 24 by Health Canada for Reveal 35C™, created by KA Imaging - a University of Waterloo spin-off company. Reveal is a portable dual-energy X-ray detector that enables bone and soft-tissue differentiation without motion

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for PyL™ (18F-DCFPyL),

CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today congratulated Orphazyme A/S (ORPHA.CO) (NASDAQ:ORPH) (“Orphazyme”) on the September 29, 2020 pricing of its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent priv

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Pfenex Inc. (NYSE American: PFNX) at an offer price of $12.00 per share in cash, plus one non-transferable contractual contingent value right per share representing the right to receive a contingent payment of $2.00 in cash, if a certain specified milesto

Sema4, a patient-centered health intelligence company, today announced that Karen White has joined the company as Chief People Officer and will lead its human capital organization.